Literature DB >> 29596552

Yield, Techniques, and Complications of Transvitreal and Transscleral Biopsies in Small Uveal Melanoma.

Ryan Sangwoo Kim1,2, Patricia Chevez-Barrios3,4,5,6, Mukul Divatia3,4, Maria Eugenia Bretana2, Bin Teh7, Amy Claire Schefler2,4,6.   

Abstract

Importance: Intraoperative adequacy check of biopsy samples can lead to a higher biopsy yield rate, and subsequent genomic analysis can provide patients with valuable prognostic information.
Objectives: To examine the yield rates for transscleral and transvitreal fine-needle aspiration biopsies of small uveal melanoma less than 3.6 mm in apical height and to discuss techniques that would maximize yield rates and minimize complications. Design, Setting, and Participants: A retrospective, consecutive observational case series was conducted from January 29, 2013, to May 23, 2017, at Retina Consultants of Houston and Houston Methodist Hospital among 44 patients with uveal melanoma of the ciliary body or choroid. Interventions or Exposures: Fine-needle aspiration biopsy and intraoperative histopathologic analysis prior to iodine 125 brachytherapy. Main Outcomes and Measures: Tumor locations and dimensions were identified by histopathologic analysis and B-scan ultrasonography. Either transscleral or transvitreal biopsy was performed for tumors anterior to the equator and posterior to the equator, respectively. Biopsy specimens were checked for adequacy intraoperatively. Specimens were examined using hematoxylin-eosin, double immunostain with human melanoma black 45 and Ki67, and gene expression profile.
Results: A total of 44 patients were included in the study, with a mean (SD) age of 63.3 (12.7) years (21 men [47.7%]; 23 women [52.3%]). Median tumor height was 2.7 mm (interquartile range, 2.3- 2.9 mm). Forty of 44 biopsy samples (90.9%; 95% CI, 82.4%-99.4%) yielded adequate cells for gene expression profile analysis. Transscleral and transvitreal yield rates were 11 of 11 (100%) and 29 of 33 (87.9%), respectively. Most localized vitreous hemorrhages were resolved by 3 months. There was a moderate association between localized vitreous hemorrhage and transvitreal biopsy method, for which the phi value was -0.526 (95% CI, -0.712 to -0.157; P < .001). Conclusions and Relevance: These findings suggest intraoperative adequacy evaluation of fine-needle aspiration biopsy specimens leads to high yield and is more informative for patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29596552      PMCID: PMC5876837          DOI: 10.1001/jamaophthalmol.2018.0561

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  21 in total

1.  Fine-needle aspiration biopsy of uveal melanoma: outcomes and complications.

Authors:  Arun D Singh; Carlos A Medina; Nakul Singh; Mary E Aronow; Charles V Biscotti; Pierre L Triozzi
Journal:  Br J Ophthalmol       Date:  2015-07-31       Impact factor: 4.638

2.  Comparison of uveal melanoma cytopathologic sample retrieval in trans-scleral versus vitrectomy-assisted transvitreal fine needle aspiration biopsy.

Authors:  Melinda Y Chang; Tara A McCannel
Journal:  Br J Ophthalmol       Date:  2014-07-04       Impact factor: 4.638

3.  Update on Ophthalmic Oncology 2012: Advances in Retinoblastoma and Uveal Melanoma.

Authors:  Amy C Schefler; David H Abramson
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2013 Mar-Apr

Review 4.  Recent developments in prognostic and predictive testing in uveal melanoma.

Authors:  Matthew G Field; J William Harbour
Journal:  Curr Opin Ophthalmol       Date:  2014-05       Impact factor: 3.761

5.  Transvitreal fine needle aspiration biopsy: the influence of intraocular lesion size on diagnostic biopsy result.

Authors:  V M Cohen; S Dinakaran; M A Parsons; I G Rennie
Journal:  Eye (Lond)       Date:  2001-04       Impact factor: 3.775

6.  Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.

Authors:  Michael D Onken; Lori A Worley; Justis P Ehlers; J William Harbour
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

7.  Fluorescent in situ hybridization for monosomy 3 via 30-gauge fine-needle aspiration biopsy of choroidal melanoma in vivo.

Authors:  Tara A Young; Nagesh P Rao; Ben J Glasgow; Joel N Moral; Bradley R Straatsma
Journal:  Ophthalmology       Date:  2006-11-09       Impact factor: 12.079

Review 8.  Transhepatic therapies for metastatic uveal melanoma.

Authors:  David J Eschelman; Carin F Gonsalves; Takami Sato
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

9.  Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death.

Authors:  Bertil Damato; Justyna Dopierala; Annelies Klaasen; Marcory van Dijk; Julie Sibbring; Sarah E Coupland
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-31       Impact factor: 4.799

10.  In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up.

Authors:  Edoardo Midena; Laura Bonaldi; Raffaele Parrozzani; Pietro P Radin; Barbara Boccassini; Stela Vujosevic
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-13       Impact factor: 3.117

View more
  5 in total

1.  Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.

Authors:  Carol L Shields; Kareem Sioufi; Archana Srinivasan; Maura Di Nicola; Babak Masoomian; Laura E Barna; Vladislav P Bekerman; Emil A T Say; Arman Mashayekhi; Jacqueline Emrich; Lydia Komarnicky; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389

2.  Multi-center analysis of intraocular biopsy technique and outcomes for uveal melanoma: Ocular Oncology Study Consortium report 4.

Authors:  Michael I Seider; Duncan E Berry; Amy C Schefler; Miguel Materin; Sandra Stinnett; Prithvi Mruthyunjaya
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-06       Impact factor: 3.117

3.  Evaluation of optical coherence tomography (OCT) changes following transretinal tumour biopsy for choroidal melanoma.

Authors:  Shah Haider; Taktak Azam; Gatchalian Leandro; Heimann Heinrich; Hussain Rumana
Journal:  Eye (Lond)       Date:  2022-07-25       Impact factor: 4.456

4.  Novel Guarded Needle Trans-Scleral Biopsy for Uveal Melanoma: A Pilot Study.

Authors:  Abtin Shahlaee; Musa Abdelaziz; Michael I Seider
Journal:  Ocul Oncol Pathol       Date:  2021-06-02

5.  Ultra-low dose external beam radiotherapy for presumed choroidal lymphoma: a case report.

Authors:  Jeremy P M Flanagan; Michael Ng; Awet Z Kibrom; Robin J A Filshie; Richard J Stawell; Roderick F O'Day
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.